Omeros (OMER) Stock Research

Over a week ago

Omeros grants new technology add-on payment status to Yartemlea

OMER

Aug 3, 8:36 AM

What You Missed On Wall Street On Monday

+22

Jul 27, 4:27 PM

Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop

+29

Jul 27, 11:55 AM

Omeros up 11% to $10.89 after AstraZeneca study failure

Jul 27, 10:11 AM

AstraZeneca miss 'clear positive' for Omeros, says H.C. Wainwright

Jul 27, 10:11 AM

Omeros price target lowered by $7 at H.C. Wainwright, here's why

OMER

Jun 26, 11:28 AM

Omeros announces CHMP adopts negative opinion on MAA for narsoplimab

OMER

Jun 26, 8:33 AM

Omeros trading resumes

OMER

Jun 12, 9:42 AM

Omeros trading halted, volatility trading pause

OMER

Jun 12, 9:32 AM

Omeros reports Q1 adjusted EPS (24c), consensus (28c)

OMER

May 13, 4:04 PM

Omeros options imply 10.8% move in share price post-earnings

OMER

May 13, 3:34 PM

Kyverna Therapeutics appoints Nadia Dac as chief commercial officer

May 4, 8:05 AM

Sagimet Biosciences appoints Grauer as Chief Medical Officer

Apr 20, 7:03 AM

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA

OMER

Apr 16, 8:46 AM

Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook

Mar 31, 7:05 PM

Omeros reports Q4 EPS $1.22, consensus 36c

OMER

Mar 31, 4:03 PM

Omeros announces completion of nonhuman primates OncotoX-AML study

OMER

Feb 17, 9:13 AM

Omeros announces first commercial sales of Yartemlea

OMER

Jan 27, 9:15 AM

Omeros price target raised by $20 at H.C. Wainwright, here's why

OMER

Jan 8, 6:05 AM

Omeros call volume above normal and directionally bullish

OMER

Dec 30, 10:45 AM

Omeros call volume above normal and directionally bullish

OMER

Dec 29, 11:45 AM

D. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy rating

OMER

Dec 24, 10:50 AM

H.C. Wainwright says Yartemlea approval 'significant validation' of Omeros value

OMER

Dec 24, 10:27 AM

Omeros trading resumes

OMER

Dec 24, 10:14 AM

Omeros up 100% at $17.55 upon resumption of trading

OMER

Dec 24, 10:09 AM

Over a week ago

Omeros grants new technology add-on payment status to Yartemlea

OMER

Aug 3, 8:36 AM

What You Missed On Wall Street On Monday

+22

Jul 27, 4:27 PM

Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop

+29

Jul 27, 11:55 AM

Omeros up 11% to $10.89 after AstraZeneca study failure

Jul 27, 10:11 AM

AstraZeneca miss 'clear positive' for Omeros, says H.C. Wainwright

Jul 27, 10:11 AM

Omeros price target lowered by $7 at H.C. Wainwright, here's why

OMER

Jun 26, 11:28 AM

Omeros announces CHMP adopts negative opinion on MAA for narsoplimab

OMER

Jun 26, 8:33 AM

Omeros trading resumes

OMER

Jun 12, 9:42 AM

Omeros trading halted, volatility trading pause

OMER

Jun 12, 9:32 AM

Omeros reports Q1 adjusted EPS (24c), consensus (28c)

OMER

May 13, 4:04 PM

Omeros options imply 10.8% move in share price post-earnings

OMER

May 13, 3:34 PM

Kyverna Therapeutics appoints Nadia Dac as chief commercial officer

May 4, 8:05 AM

Sagimet Biosciences appoints Grauer as Chief Medical Officer

Apr 20, 7:03 AM

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA

OMER

Apr 16, 8:46 AM

Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook

Mar 31, 7:05 PM

Omeros reports Q4 EPS $1.22, consensus 36c

OMER

Mar 31, 4:03 PM

Omeros announces completion of nonhuman primates OncotoX-AML study

OMER

Feb 17, 9:13 AM

Omeros announces first commercial sales of Yartemlea

OMER

Jan 27, 9:15 AM

Omeros price target raised by $20 at H.C. Wainwright, here's why

OMER

Jan 8, 6:05 AM

Omeros call volume above normal and directionally bullish

OMER

Dec 30, 10:45 AM

Omeros call volume above normal and directionally bullish

OMER

Dec 29, 11:45 AM

D. Boral Capital notes Omeros' YARTEMLEA FDA win, maintains Buy rating

OMER

Dec 24, 10:50 AM

H.C. Wainwright says Yartemlea approval 'significant validation' of Omeros value

OMER

Dec 24, 10:27 AM

Omeros trading resumes

OMER

Dec 24, 10:14 AM

Omeros up 100% at $17.55 upon resumption of trading

OMER

Dec 24, 10:09 AM

Company News

Charts